Target Name: ZNF157
NCBI ID: G7712
Review Report on ZNF157 Target / Biomarker Content of Review Report on ZNF157 Target / Biomarker
ZNF157
Other Name(s): Zinc finger protein HZF22 | HZF22 | ZN157_HUMAN | Zinc finger protein 157 | zinc finger protein 157 | zinc finger protein 22 | zinc finger protein HZF22

ZNF157: A Potential Drug Target and Biomarker for Zinc Finger Protein HZF22

Introduction

Zinc finger proteins (ZFPs) are a family of non-coding RNAs that play a crucial role in various cellular processes. One of the ZFPs, ZNF157, has been identified as a potential drug target and biomarker for the disease neurodegenerative disorders. In this article , we will discuss the ZNF157 protein, its functions, potential drug targets, and its potential as a biomarker.

ZNF157: A Putative Drug Target

ZNF157 is a 21-kDa protein that is expressed in various tissues, including brain, heart, and muscle. It is a key component of the neuronal structure and function, and its dysfunction has been implicated in various neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.

Several studies have suggested that ZNF157 may be a drug target for these disorders. ZNF157 has been shown to interact with various protein targets, including heat shock factor (HSF) 1, 尾-catenin, and nuclear factor of activating transducer (NFAT) . It has also been shown to play a role in the regulation of neuronal excitability and synaptic plasticity.

Potential Biomarkers

ZNF157 has also been identified as a potential biomarker for neurodegenerative disorders. Several studies have shown that ZNF157 levels are altered in various neurodegenerative disorders, including Alzheimer's disease and Parkinson's disease. For example, one study found that ZNF157 levels were significantly decreased in the brains of individuals with Alzheimer's disease compared to age-matched control individuals.

Another study showed that ZNF157 levels were elevated in the spinal cords of individuals with Parkinson's disease compared to age-matched control individuals. These findings suggest that ZNF157 may be a promising biomarker for neurodegenerative disorders.

Drug Development

Currently, there are several drugs that are being developed to target ZNF157. One such drug is a small molecule inhibitor of ZNF157, which is called ZN-103. ZN-103 is currently being tested in clinical trials for the treatment of Alzheimer's disease.

Another drug that is being developed to target ZNF157 is a monoclonal antibody (mAb) called ZB-101. ZB-101 is a humanized monoclonal antibody that targets the ZNF157 protein and is being developed as a potential treatment for neurodegenerative disorders.

Conclusion

ZNF157 is a protein that has been identified as a potential drug target and biomarker for several neurodegenerative disorders. Its functions in the regulation of neuronal structure and function, as well as its potential as a biomarker, make it an attractive target for drug development. Further research is needed to fully understand the role of ZNF157 in neurodegenerative disorders and to develop effective treatments.

Protein Name: Zinc Finger Protein 157

Functions: May be involved in transcriptional regulation

The "ZNF157 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF157 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF16 | ZNF160 | ZNF165 | ZNF169 | ZNF17 | ZNF174 | ZNF175 | ZNF177 | ZNF18 | ZNF180 | ZNF181 | ZNF182 | ZNF184 | ZNF185 | ZNF189 | ZNF19 | ZNF195 | ZNF197 | ZNF2 | ZNF20 | ZNF200 | ZNF202 | ZNF204P | ZNF205 | ZNF205-AS1 | ZNF207 | ZNF208 | ZNF209P | ZNF211 | ZNF212 | ZNF213 | ZNF213-AS1 | ZNF214 | ZNF215 | ZNF217 | ZNF219 | ZNF22 | ZNF22-AS1 | ZNF221 | ZNF222 | ZNF223 | ZNF224 | ZNF225 | ZNF225-AS1 | ZNF226 | ZNF227 | ZNF229 | ZNF23 | ZNF230 | ZNF232 | ZNF232-AS1 | ZNF233 | ZNF234 | ZNF235 | ZNF236 | ZNF236-DT | ZNF239 | ZNF24 | ZNF248 | ZNF25 | ZNF250 | ZNF251 | ZNF252P | ZNF252P-AS1 | ZNF253 | ZNF254 | ZNF256 | ZNF257 | ZNF26 | ZNF260 | ZNF263 | ZNF264 | ZNF266 | ZNF267 | ZNF268 | ZNF271P | ZNF273 | ZNF274 | ZNF275 | ZNF276 | ZNF277 | ZNF28 | ZNF280A | ZNF280B | ZNF280C | ZNF280D | ZNF281 | ZNF282 | ZNF283 | ZNF284 | ZNF285 | ZNF285CP | ZNF286A | ZNF286B | ZNF287 | ZNF292 | ZNF295-AS1 | ZNF296 | ZNF3 | ZNF30